Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tron Inc.TRON · Entity 5156 | Director · 10% owner | August 27, 2025 | April 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tron Inc.
Report date August 27, 2025 · Filed April 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 420,000,000 |
Last balance in matching sequence
After 2026-04-02 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2025-08-27 · Grant · Acquired 220,000,000 · Balance 220,000,000 F1: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. Row 2 · 2026-04-02 · Grant · Acquired 200,000,000 · Balance 420,000,000 F1: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. |
| Common Stock Purchase WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2027-06-16 | IndirectSee footnote | 0 |
Reported balance
After 2025-08-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-08-27 · Exercise / conversion · Disposed 220,000,000 · Balance 0 F2: On August 27, 2025, Bravemorning exercised the PIPE Warrants in full and, on August 29, 2025, the Registrant issued 220,000,000 shares of Common Stock to Bravemorning. The Holder paid $110,000,000 to the Registrant in the form of 312,500,100 TRX as consideration for the issuance of these Common Stock shares. F1: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. |
| Series B Convertible Preferred StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 | IndirectSee footnote | 0 |
Reported balance
After 2026-04-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-02 · Exercise / conversion · Disposed 200,000,000 · Balance 0 F4: On April 2, 2026, the Registrant received a conversion notice from Bravemorning to convert all of its 100,000 shares of Series B Preferred Stock and, on April 2, 2026, the Registrant issued 200,000,000 shares of Common Stock to Bravemorning. F3: These securities do not have an expiration date. F1: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX.
F2: On August 27, 2025, Bravemorning exercised the PIPE Warrants in full and, on August 29, 2025, the Registrant issued 220,000,000 shares of Common Stock to Bravemorning. The Holder paid $110,000,000 to the Registrant in the form of 312,500,100 TRX as consideration for the issuance of these Common Stock shares.
F3: These securities do not have an expiration date.
F4: On April 2, 2026, the Registrant received a conversion notice from Bravemorning to convert all of its 100,000 shares of Series B Preferred Stock and, on April 2, 2026, the Registrant issued 200,000,000 shares of Common Stock to Bravemorning.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2026 Filed Apr 9, 2026 01:28 UTC | Tron Inc. TRON · Entity 5156 | Exercise / conversionSeries B Convertible Preferred Stock · Derivative | 200,000,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001493152-26-015786 · ownership.xml · derivative · entry 4 SUN Weike · CIK 0002075156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 200,000,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: On April 2, 2026, the Registrant received a conversion notice from Bravemorning to convert all of its 100,000 shares of Series B Preferred Stock and, on April 2, 2026, the Registrant issued 200,000,000 shares of Common Stock to Bravemorning. F3 · derivative.expiration_date: These securities do not have an expiration date. F1 · ownership.nature: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. Read SEC document |
| April 02, 2026 Filed Apr 9, 2026 01:28 UTC | Tron Inc. TRON · Entity 5156 | GrantCommon Stock | 200,000,000 | $0.50 | $100,000,000.00 |
DisclosureSEC source: 0001493152-26-015786 · ownership.xml · nonDerivative · entry 2 SUN Weike · CIK 0002075156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 420,000,000 F1 · ownership.nature: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. Read SEC document |
| August 27, 2025 Filed Apr 9, 2026 01:28 UTC | Tron Inc. TRON · Entity 5156 | Exercise / conversionCommon Stock Purchase Warrants · Derivative | 220,000,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001493152-26-015786 · ownership.xml · derivative · entry 3 SUN Weike · CIK 0002075156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 220,000,000 shares Expires 2027-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: On August 27, 2025, Bravemorning exercised the PIPE Warrants in full and, on August 29, 2025, the Registrant issued 220,000,000 shares of Common Stock to Bravemorning. The Holder paid $110,000,000 to the Registrant in the form of 312,500,100 TRX as consideration for the issuance of these Common Stock shares. F1 · ownership.nature: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. Read SEC document |
| August 27, 2025 Filed Apr 9, 2026 01:28 UTC | Tron Inc. TRON · Entity 5156 | GrantCommon Stock | 220,000,000 | $0.50 | $110,000,000.00 |
DisclosureSEC source: 0001493152-26-015786 · ownership.xml · nonDerivative · entry 1 SUN Weike · CIK 0002075156 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 220,000,000 F1 · ownership.nature: The reported securities are held directly by Bravemorning Limited ("Bravemorning"). Mr. Weike Sun is the sole shareholder of Bravemorning and may be deemed to beneficially own the securities held by Bravemorning. On June 16, 2025, Bravemorning purchased (i) 100,000 shares of Series B Convertible Preferred Stock, convertible into 200,000,000 shares of the Registrant's common stock at a conversion price of $0.50 per share and (ii) warrants to purchase up to 220,000,000 shares of the Registrant's common stock at an exercise price of $0.50 per share (the "PIPE Warrants") with the consideration of $100,000,000 paid in the form of 365,096,845 TRX. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.